Condition
Pancreatitis, Chronic clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Pancreatitis, Chronic clinical trials that are recruiting, at sites in 4 countries (most in Czechia (2), China (1), United States (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Pancreatitis, Chronic clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Microbial pancreatic enzyme therapy versus porcine enzyme in chronic pancreatitis with exocrine pancreatic insufficiency | Phase 3 | Hyderabad, Telangana | Recruiting | Jul 13, 2026 |
| Indometacin with or without extra IV fluids to prevent pancreatitis after pancreatic stone shock-wave treatment | — | Baotou and 9 other locations | Recruiting | Oct 2, 2025 |
| Comparing pioglitazone and empagliflozin for diabetes in chronic pancreatitis patients | Phase 2 | Rochester, Minnesota and 2 other locations | Recruiting | Dec 12, 2024 |
| Using Lipidica software to screen for pancreatic cancer in high-risk patients | — | Prague, Czechia and 15 other locations | Recruiting | Aug 12, 2024 |
| Screening for pancreatic cancer in high-risk individuals | — | Brno | Recruiting | Mar 26, 2024 |
All recruiting trials (5)
-
Microbial pancreatic enzyme therapy versus porcine enzyme in chronic pancreatitis with exocrine pancreatic insufficiency
This study tests whether a microbial (fungal) pancreatic enzyme product can work as well as the standard porcine enzyme in adults with chronic pancreatitis and PEI.
-
Indometacin with or without extra IV fluids to prevent pancreatitis after pancreatic stone shock-wave treatment
This study will test whether giving aggressive intravenous fluids in addition to rectal indometacin reduces the chance of pancreatitis after ESWL for pancreatic stones.
-
Comparing pioglitazone and empagliflozin for diabetes in chronic pancreatitis patients
This study is testing whether the diabetes medications pioglitazone or empagliflozin can help people with chronic pancreatitis control their blood sugar better.
-
Using Lipidica software to screen for pancreatic cancer in high-risk patients
This study is testing a new software called Lipidica to see if it can help find pancreatic cancer earlier in people who are at high risk because of their genetics or family history.
-
Screening for pancreatic cancer in high-risk individuals
This study is testing different ways to screen people at high risk for pancreatic cancer to see if early detection can help them live longer.
Related topics
Quick answers
How many Pancreatitis, Chronic clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Czechia (2 trials), China (1 trial), United States (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.